Approval · Notice of Compliance 18796 · 2016
KYPROLIS: Notice of Compliance 18796
Issued December 20, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18796
- Date
- December 20, 2016
- Company
- Amgen Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strengths: 10 mg/vial and 30 mg/vial; and updates to the curremntly approved 60 mg/vial presentation
Products in this notice
Medicinal ingredients
- CARFILZOMIB 30 MG per VIAL
- CARFILZOMIB 10 MG per VIAL
- CARFILZOMIB 60 MG per VIAL